The CACT is a good investment
MedTech has recognized the CACT as a good business investment for ceramic research.
The CACT was awarded the 2013 Academic Member Excellence Award by MedTech, an association of pharmaceutical, biotech and medical technology companies. It received the award specifically for its return on investment.
MedTech President Jessica Crawford presented Barry Watkins, CACT Deputy Director, with the award in June 2014.
The CACT received the award for three reasons, according to Amy Spranger, manager of Member Development and Retention. First, AU received that year $2.8 million in NYS regional development funding. Second, AU collaborated with Solid Cell of Rochester on a NYSERDA funded solid oxide fuel cell project. Third the CACT's economic impact, according to the latest audit, was $54 to $1.
AU Press Releases